Efficacy of Physical Exercise to Offset Anthracycline‐Induced Cardiotoxicity: A Systematic Review and Meta‐Analysis of Clinical and Preclinical Studies

Abstract

Background Physical exercise is an intervention that might protect against doxorubicin‐induced cardiotoxicity. In this meta‐analysis and systematic review, we aimed to estimate the effect of exercise on doxorubicin‐induced cardiotoxicity and to evaluate mechanisms underlying exercise‐mediated cardioprotection using (pre)clinical evidence. Methods and Results We conducted a systematic search in PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Cochrane's and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk‐of‐bias tools were used to assess the validity of human and animal studies, respectively. Cardiotoxicity outcomes reported by ≥3 studies were pooled and structured around the type of exercise intervention. Forty articles were included, of which 3 were clinical studies. Overall, in humans (sample sizes ranging from 24 to 61), results were indicative of exercise‐mediated cardioprotection, yet they were not sufficient to establish whether physical exercise protects against doxorubicin‐induced cardiotoxicity. In animal studies (n=37), a pooled analysis demonstrated that forced exercise interventions significantly mitigated in vivo and ex vivo doxorubicin‐induced cardiotoxicity compared with nonexercised controls. Similar yet slightly smaller effects were found for voluntary exercise interventions. We identified oxidative stress and related pathways, and less doxorubicin accumulation as mechanisms underlying exercise‐induced cardioprotection, of which the latter could act as an overarching mechanism. Conclusions Animal studies indicate that various exercise interventions can protect against doxorubicin‐induced cardiotoxicity in rodents. Less doxorubicin accumulation in cardiac tissue could be a key underlying mechanism. Given the preclinical evidence and limited availability of clinical data, larger and methodologically rigorous clinical studies are needed to clarify the role of physical exercise in preventing cardiotoxicity in patients with cancer. Registration URL: https://www.crd.york.ac.uk/prospero ; Unique identifier: CRD42019118218.

Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity - a randomized controlled trial.

“…Our findings can be explained by biologically plausible mechanisms and experimentally demonstrated results from animal studies. 19 The dose-response relationship found in our and a self-reported previous study 20 are suggestive of a causal relationship. Nevertheless, larger studies are needed to confirm our results and provide consistent evidence.…”

Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study

“…10 However, there are limited randomized data establishing sustained benefit or evidence linking ExT to favorable changes in cardiac function and functional disability in patients with BC. 10,11…”

Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors

“… 37 , 38 First, from a biological standpoint, a protective effect of physical activity on subclinical cardiac dysfunction is plausible given that preclinical studies describe various pathways via which physical exercise can yield cardioprotection during and after treatment, including less chemotherapy accumulation in the myocardium following physical exercise. 39 Second, it seems less likely that subclinical cardiac dysfunction results in lower physical activity levels because patients are unlikely to experience symptoms solely from impaired GLS with LVEF in normal ranges. Third, the observed effect of physical activity on cardiac dysfunction is consistent with previous evidence from randomized studies in noncancer populations, documenting beneficial effects of physical exercise on cardiac function, including LVEF.…”